title: Hyperthyroidism and the management of atrial fibrillation.
abstract: Atrial fibrillation is often induced in patients with hyperthyroidism and may trigger heart failure. Its prevalence and outcome were examined to obtain up-to-date information. Persistent atrial fibrillation was observed in approximately 1.7% of new hyperthyroid patients. It occurs more frequently in males (2.86%) than in females (1.36%), even though the number of male hyperthyroid patients is only one fifth of female patients. The rate increased with age, being 8% in the patients older than 70 years old. The initial treatment is to control the heart rate with routine pharmacologic therapy and to start antithyroid therapy as quickly as possible. Attempted cardioversion should be deferred until approximately the fourth month of maintaining a euthyroid state, because more than 56% of atrial fibrillation spontaneously reverts to sinus rhythm when the thyroid hormone levels start to decline. Elective cardioversion for those whose atrial fibrillation persists is highly effective and sinus rhythm maintenance rates were 56.7% and 47.6% at the 10th and the 14th year, respectively, even though the duration of atrial fibrillation prior to cardioversion was extremely long (35.0 +/- 29.0 months).
authors.affiliation: Ito Hospital, Tokyo, Japan.
authors.forename: Taeko
authors.initials: T
authors.lastname: Shimizu
authors.forename: Saori
authors.initials: S
authors.lastname: Koide
authors.forename: Jaduk Yoshimura
authors.initials: JY
authors.lastname: Noh
authors.forename: Kiminori
authors.initials: K
authors.lastname: Sugino
authors.forename: Kohichi
authors.initials: K
authors.lastname: Ito
authors.forename: Hiroe
authors.initials: H
authors.lastname: Nakazawa
mesh_terms: D000367:Age Factors; D001281:Atrial Fibrillation / Q000150:complications* / Q000628:therapy*; D004554:Electric Countershock; D004562:Electrocardiography; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications*; D008297:Male; D013997:Time Factors; D016896:Treatment Outcome